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Abstract 
Out of various pathologies that affect the liver, focal liver lesion form an important group. Triphasic computed 
tomography is the imaging modality most often used to evaluate focal liver lesions. The purpose of this study was 
to evaluate the role of computed tomography in the diagnosis of liver lesions and to determine frequency of these 
lesions.  
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Introduction 
Any lesions in the liver other than normal parenchyma which may or may not cause structural and functional 
abnormality of hepatobiliary system are defined as focal liver lesions. They can be of variable size. The prevalence 
of these lesions is different across geographic regions and ethnic groups. These lesions can be divided into benign 
and malignant.1 There is wide spectrum of benign focal lesions. Most common amongst them are cysts, 
hemangiomas, hepatocellular adenomas (HCA) and focal nodular hyperplasia (FNH). Focal liver lesions mostly 
represent metastatic deposit than primary malignancy in Europe and United States. In Pakistan hepatocellular 
carcinoma is the fourth most common hepatic disorder.2  
The liver is the largest organ in the body. Anatomically, the  liver is divided into right and left lobe by the 
landmark of falciform ligament that runs along the umbilical fissure and holds the liver to the anterior abdominal 
wall.(Fig, 1). Out of the total liver mass, right lobe accounts for 60-70% and remainder is in the left lobe and 
caudate lobe. Caudate lobe lies to the left and anterior to inferior vena cava. The right lobe can be further divided 
into anterior and posterior and the left lobe into medial and lateral segments.3 Because of its function 
(detoxification) and rich blood supply by hepatic artery and portal vein, liver is prone to various diseases including 
benign and malignant. Most primary and metastatic hepatic lesions, receives their blood supply from hepatic artery, 
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reverses the normal proportion of hepatic blood supply which is mainly supplied by portal vein (70%) to the hepatic 
artery which becomes the prime source of blood supply. The triphasic scan of liver is possible due to this difference 
in pattern of blood flow. This technique has helped to evaluate the imaging features of primary metastatic liver 
lesions. Liver triphasic scan is very crucial in distinguishing a benign from malignant lesion and avoid unnecessary 
invasive procedures especially in benign lesions like hemangioma.4, 5 
CT triphasic technique is an imaging modality which is used in the evaluation of focal liver lesions and is 
widely accepted as it can image entire liver in arterial, portal venous and delayed phases.6 The diagnostic workup 
of focal hepatic lesion includes different radiological tests and pathology i.e biopsy if indicated. However, biopsy 
can be avoided in many patients if diagnosis established on triphasic CT scan. Focal hepatic lesion in patients with 
chronic liver disease is always suspicious for hepatocellular carcinoma.7, 8 Because of high frequency of benign 
focal lesions such as cysts, carcinomas and metastasis in patients with chronic liver disease (CLD) early detection 
is necessary to reduce the rates of mortality and morbidity. The portal phase is the most sensitive phase for lesion 
detection, whereas the arterial and delayed venous phases provide information about vascularity of lesion and help 
in characterization of lesion.9  
Mostly, incidentally noted focal liver lesions are benign, it may be difficult to differentiate benign lesion from 
those that are malignant. Furthermore, it is important to remember that some noncancerous lesions such as 
hepatocellular adenomas and biliary cystadenomas have malignant potential. These lesions may not necessarily 
present with symptoms attributable to the lesion and are frequently not associated with underlying liver disease. 
Thus, the clinical circumstance in which a focal liver lesion is identified, such as patient’s age, gender and history 
of chronic liver disease, may provide vital clues to the etiology. The presence of underlying chronic liver disease, 
either suspected or proven by clinical and laboratory features, as well as the time of detection of the lesion.10 
Current literature shows that in detection and characterization of focal liver lesions magnetic resonance 
imaging (MRI) has a comparable rate. However, ease of availability and short scanning time has made CT an ideal 
technique.11, 12 It is reported in recent studies that an improvement is seen in lesion detection if arterial phase is 
performed in addition to portal venous phase spatially in the presence of hyper-vascular neoplasm, such as 
hepatocellular carcinoma, similarly, cirrhosis and its associated altered portal venous blood flow can help to reveal 
more focal lesion on the arterial phase than on the portal venous phase.13 Several studies have been done worldwide 
on the role of triphasic CT scan in characterizing and differentiating benign and malignant lesions. In recent years 
triphasic computed tomography has evolved as the procedure of choice for the detection and characterization of 
benign and malignant hepatic lesion. Since, triphasic CT scanners are widely available in Pakistan and worldwide, 
it is very important to understand their performance capabilities for evaluation and assessment of focal hepatic 
lesions. The aim of our study was to determine the role of triphasic computed tomography in the evaluation of 
focal hepatic lesions and to determine the frequency of these lesions on triphasic CT scan (Note 1) 
 
Methods 
It was a descriptive study. 75 patients suffering from focal hepatic lesions attending Radiology Department of The 
University of Teaching Hospital, Services Hospital and Jinnah Hospital Lahore were selected. The estimated 
duration of study was 4 months. While patients suffering from diffuse hepatic disease were not included in the 
study. The scanning of focal hepatic lesions was performed through TOSHIBA 128 Model: Tsx-101A/AQ 
computed tomography machine and using 120kvp, 220mAs, Pitch 53.0 and 400 collimation. Observations were 
made on CT triphasic scan. The information regarding quantitative and qualitative variables such as age, gender, 
history and lesion appearance on different phases were recorded. Microsoft excel and SPSS version 24.0 were 




There were 75 participants in the study with the age group of 17- 80 years, the maximum number of patients were 
from the age group 40-80 years. The mean age was 48.5 years. The mean and standard deviation were 55.24± 
12.10 years. Twenty seven patients (36.0%) were female and forty eight (64.0%) were male. The presenting 
complaints were fever in 41(54.7%) patients, abdominal pain in 69 (92.0%) patients and with the history of CLD 
(chronic liver disease) in 28 (37.3%) patients, hepatitis C in 37 (49.3%) patients and cancer of other organs in 
seven (9.3%) patients (Table 1) (Figure 1) 
 
Discussion  
Triphasic liver computed tomography scan has gained acceptance as the preferred computed tomography 
technique for routine liver evaluation and it has helped in the decline of mortality and morbidity rates among 
patients with liver disease. It also enables fast data acquisition from the entire liver at different intervals after 
injection of contrast material. So triphasic liver CT scan is a standardized procedure for the detection and 
characterization of a large variety of focal liver lesions.14, 15  Our study documented 50 (66.67%) malignant lesions 
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and 25 (33.33%) benign lesions. Out of the total fifty malignant lesions, forty two (84%) were hepatocellular 
carcinoma and eight (16%) were metastatic lesions. These results showed hepatocellular carcinoma to be the most 
common malignant lesion with the percentage of 84% (out of 50 malignant lesions) and our results are similar to 
the study conducted in 2019 that found HCC to be the most common malignant lesion at 44.2%. In this study 44 
(86.3%) were diagnosed to be malignant and seven (13.7%) were benign. On later histological evaluation, 43 
(84.3%) were malignant and eight (15.7%) were benign. In this study, 35 (57.4%) were in males and 26 (42.6%) 
were in females. There were 40 true positive, four false positive, four true negative and three false negative results 
reported on CT based assessment of liver lesions.16 In our study, out 42 (84%) HCC patients, 27 (64.29%) were in 
male and 12 (35.71%) in females. Out of the eight metastatic lesions five (62.5%) were in female and three (37.5%) 
were in males. Out of total, benign lesions hemangiomas were in 17 (22.67%) patients, 2 (2.67%) were hydatid 
cysts, 2 (2.67%) were polycystic liver disease, 3 (4.0%) were simple cysts and one (1.33%) focal fatty mass was 
diagnosed. According to a study in 2011, the hyper-vascular primary malignancies (e.g. hepatocellular carcinoma) 
and secondary malignancies (e.g. metastasis) have a proportionately greater arterial blood supply and may be 
visible only on hepatic arterial phase images. Most of the hypervascular metastatic lesions were best visualized on 
arterial phase images as compared to portal venous phase images. Primary malignancies such as hepatocellular 
carcinoma show enhancement on arterial phase so they can also best visualized during the arterial phase.17 In our 
study, all of the 42 hepatocellular carcinomas presented as hyper or mixed density lesions; 40 were detected only 
on arterial phase and two were better seen on portal venous phase. All hyper or mixed density lesions during 
arterial phase occurring in patients with chronic liver disease represent hepatocellular carcinoma lesions. So the 
lesion seen during hepatic arterial phase may require biopsy. In patients with hyper vascular malignancies such as 
HCC, detection and characterization of small lesion is important because these lesions are more likely to be 
resectable (able to remove by surgery) than the larger lesions. Arterial phase images are helpful for the detection 
of hyper-vascular and essential for the characterization of large percentage of lesions. Delayed phase image further 
aid in lesion characterization. Noncontrast CT examination helps in the detection of fatty and fibrotic changes in 
the lesions which may not be seen after contrast administration.18 Similarly two other studies conducted in 2011 
and 2012, reported that HCC shows characteristic enhancement compared to surrounding liver parenchyma in 
arterial phase, washout of contrast in portal venous phase and are hypo-dense in delayed phase. This enhancement 
pattern is considered diagnostic of HCC in cirrhotic liver. However, some HCC lesions do not follow this pattern. 
Some hyper-vascular HCCs do not demonstrate washout of contrast on portal venous and delayed phases. While, 
other lesions both benign and malignant, show washout.19, 20  
The results demonstrate that triphasic CT scan is the best modality for the detection and characterization of 
different types of focal hepatic lesions with a sensitivity of 80-100%. It is good noninvasive tool for the diagnosis 
and differentiation of benign from malignant liver lesions, therefore the invasive and unnecessary biopsy technique 
can be avoided in most or some cases. 
 
Conclusions: 
Triphasic liver computed tomography scan enables us to characterize a wide variety of focal hepatic lesions 
including both benign and malignant lesions, so invasive biopsy procedures can be avoided in many cases.  
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Notes 
Table 1 Frequency and percentage of gender distribution, patient history, lesion appearance on different scanning 
phases, lesion number distribution and final diagnosis. 
N=75  Frequency Percentage% 
GENDER 
Male  48 64.0 
Female 27 36.0 
HISTORY 
CLD 28 37.33 
Hepatitis C 37 49.33 
Fever 42 56.0 
Abdominal pain 69 92.0 
Cancer 7 9.33 
LESION ON CT 
Non-contrast 11 14.67 
Arterial phase 66 88.0 
Portal venous phase 23 30.67 
Delayed phase 9 12.00 
LESION NO 
Multiple 34 45.33 
Single 41 54.67 
FINAL DIAGNOSIS 
HCC 42 56.0 
Hemangioma 17 22.67 




Simple cyst 3 4.00 
Polycystic liver disease 2 2.67 
Focal fatty area 1 1.33 
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Figure 1. Analysis of different types of focal hepatic lesions after diagnosis on triphasic computed tomography 
scan in adult patients 
 
 
Figure 2: CT image liver with irregular margins and multiple ill-defined hypo-dense lesions in all 
segments of both lobes. These lesions show peripheral enhancement. These features are suggestive 
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